Breast imaging sales will rise through 2036, driven by ionizing breast imaging at 73.7% of the technology type segment in 2026. The market was valued at USD 5.60 billion in 2025 and is expected to be worth USD 10.52 billion by 2036, creating an incremental opportunity of USD 6.16 billion.